by Suzanne Hayes | Feb 16, 2018 | Blog
MPs were told in December that UK patient involvement in clinical trials will diminish post-Brexit making manufactures less likely to invest here. They were also told that unlocking the potential of patient data held by the NHS may be enough to persuade the...
by Suzanne Hayes | Feb 12, 2018 | Blog
Do you keep your RP informed? Is your RP aware of the little problems you’ve encountered along the way? And the seemingly harmless solutions you’ve applied…
by John Finey | Feb 2, 2018 | Behind the scenes, Blog, Brexit, Business, public speaking
Following a bun fight between 19 EU countries and a failure to agree on the new location of the EMA within the group of EU foreign ministers the decision was made by tossing a coin, at least it wasn’t ‘Rock, Paper, Scissors’! Amsterdam won through meaning that...
by Jackie (née Heneghan) Peck | Jan 19, 2018 | Blog, Business, Community Pharmacy, Good Distribution Practice - GDP, NHS, Pharmacist
It is with sadness that I reflect on the news of 2017 and the start of 2018. A&E is in crisis and there are no free appointments in GP practices, and yet Pharmacies are closing as they are not viable. What is the cheapest health care intervention? The...
by John Finey | Jan 8, 2018 | Blog, Pharmacist
Scenario 1 Patient asks for advice about travelling with medication to a north African resort for three weeks and wanted to know how they should best store their medication. Given that they had been told that their accommodation included a fridge the patient asked...
by Sandeep Lyall | Dec 22, 2017 | Blog
With official figures showing pregabalin related deaths to 111 and gabapentin related deaths to 59, the Home Office launched on 13th November three options for the reclassification of these two drugs. The options for its reclassification includes schedule 3, this...
